.svg){kind=small}
Jul-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Where to Buy
Doctor Solomon's is stocked at 623 licensed dispensaries across Illinois, Pennsylvania, and 9 other states, 130 of them in Illinois, with the deepest coverage in Chicago, Springfield, Addison, East Dubuque, and Joliet. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
Doctor Solomon's mix in July 2026 tilted toward Topical at 47.74% share with an 8.01% month-over-month lift despite a 23.41% year-over-year decline, while Tincture & Sublingual held 33.33% share with a 3.06% MoM rise against a 23.60% YoY drop; in contrast, Concentrates fell to 18.93% share with a 40.04% MoM contraction and a 35.31% YoY decline. Against a brandwide sales change of -26.11% YoY and a -12.84% YoY average price shift to $27.57, the mix shift concentrates exposure away from the steepest-declining vertical and concentrates growth into Topical and Tincture & Sublingual, implying the portfolio is consolidating around slower-declining, price-sensitive formats.
With Concentrates ranked 17th in Maryland and shrinking 40.04% MoM versus Topical’s 8.01% MoM increase, the brand’s positioning increasingly hinges on therapeutic-use formats where lower price points (-12.84% YoY) can convert share stability into volume. The divergence between a 23.41–23.60% YoY pullback in Topical and Tincture & Sublingual versus a 35.31% YoY drop in Concentrates suggests reallocating attention toward the two larger, steadier categories to defend overall rank while treating Concentrates as a selective presence rather than a volume driver.
Competitive Landscape
Doctor Solomon's is ranked #17 in MD Concentrates in July 2026, down 2 positions year over year from #15 and off 1 spot versus April 2026’s #16, while also sitting 8 ranks below its peak of #9 reached in October 2024; in contrast, District Cannabis held #1 both this year and last as its sales grew 58.7% year over year, and Grassroots moved up from #4 to #2 alongside 49.1% sales growth. The combination of a 2-rank YoY slide and a 1-rank softening over the last three months, against competitors advancing 2–3 ranks or maintaining #1, implies Doctor Solomon's is ceding share of consumer preference in Concentrates rather than cycling through temporary volatility.
Notable Products
THC Rich Rescue Transdermal Lotion (200mg, 1.8oz) posted the standout move in July 2026 with a +58.6% month-over-month surge to $23,126 while climbing into rank 6, contrasting with CBD/THC 3:1 Unwind Transdermal Balm (135mg CBD, 45mg THC) which fell -21.9% to rank 5, signaling diverging demand within high-THC versus CBD-leaning topicals. CBD/THC 1:1 Restore Transdermal Lotion (100mg CBD, 100mg THC, 1oz) rose +27.8% to hold rank 1, whereas its higher-dosage counterpart CBD/THC 1:1 Restore Transdermal Lotion (200mg CBD, 200mg THC, 1.8oz) slipped -5.5% at rank 3, indicating price-size sensitivity inside the 1:1 franchise. With six of the top ten SKUs in Topical and the leading two ranks occupied by topical formats, the mix points to Doctor Solomon's leaning further into transdermal solutions where higher THC concentration and smaller pack sizes are gaining share.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
